Lilly(Eli) Target Price

See Lilly(Eli)'s analyst price targets ($1.3K) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1,148.2

Average Target Price

$1339.60

16.7% upside

20 analysts in the last 4 months

High: $1500 | Low: $1119

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	UBS	$1,376	19.8% upside
2026-08-06	Morgan Stanley	$1,419	23.6% upside
2026-08-06	Wells FargoMohit Bansal	$1,330	15.8% upside
2026-08-06	BMO CapitalEvan Seigerman	$1,400	21.9% upside
2026-08-06	Cantor Fitzgerald	$1,410	22.8% upside
2026-07-14	Bernstein	$1,385	20.6% upside
2026-07-13	UBS	$1,425	24.1% upside
2026-07-13	Guggenheim	$1,273	10.9% upside
2026-07-09	UBS	$1,370	19.3% upside
2026-07-08	Truist Financial	$1,370	19.3% upside
2026-07-08	Morgan StanleyTerence Flynn	$1,347	17.3% upside
2026-07-08	RBC Capital	$1,500	30.6% upside
2026-07-06	Cantor Fitzgerald	$1,350	17.6% upside
2026-06-25	Leerink PartnersDavid Risinger	$1,232	7.3% upside
2026-06-22	Berenberg BankKerry Holford	$1,135	1.1% downside
2026-06-09	Jefferies	$1,350	17.6% upside
2026-05-26	HSBC	$1,251	9% upside
2026-05-26	Leerink PartnersDavid Risinger	$1,119	2.5% downside
2026-05-21	Wolfe Research	$1,350	17.6% upside
2026-05-05	BarclaysEmily Field	$1,400	21.9% upside
2026-05-01	Cantor FitzgeraldCarter Gould	$1,230	7.1% upside
2026-05-01	Morgan Stanley	$1,344	17.1% upside
2026-04-10	Morgan Stanley	$1,327	15.6% upside
2026-03-13	JefferiesAkash Tewari	$1,300	13.2% upside
2026-03-06	Deutsche BankJames Shin	$1,285	11.9% upside
2026-03-05	Morgan StanleyTerence Flynn	$1,313	14.4% upside
2026-02-24	RBC CapitalTrung Huynh	$1,250	8.9% upside
2026-02-19	Barclays	$1,350	17.6% upside
2026-02-10	Loop Capital MarketsIlya Zubkov	$1,200	4.5% upside
2026-02-05	Truist Financial	$1,281	11.6% upside
2026-02-05	Scotiabank	$1,300	13.2% upside
2026-02-05	Goldman Sachs	$1,260	9.7% upside
2026-02-05	BMO CapitalEvan Seigerman	$1,300	13.2% upside
2026-02-05	Wells FargoMohit Bansal	$1,280	11.5% upside
2026-01-20	Guggenheim	$1,161	1.1% upside
2026-01-06	UBSMichael Yee	$1,250	8.9% upside
2026-01-05	Leerink PartnersDavid Risinger	$1,234	7.5% upside
2025-12-16	DaiwaNarumi Nakagiri	$1,230	7.1% upside
2025-12-15	Goldman Sachs	$1,145	0.3% downside
2025-12-10	HSBC	$1,070	6.8% downside
2025-12-04	BMO Capital	$1,200	4.5% upside
2025-12-03	Guggenheim	$1,163	1.3% upside
2025-12-02	BMO CapitalEvan Seigerman	$1,100	4.2% downside
2025-12-01	National BankTim Anderson	$1,286	12% upside
2025-11-24	Morgan StanleyTerence Flynn	$1,290	12.3% upside
2025-11-24	Bernstein	$1,300	13.2% upside
2025-11-19	Truist FinancialSrikripa Devarakonda	$1,182	2.9% upside
2025-11-10	Loop Capital MarketsIlya Zubkov	$950	17.3% downside
2025-10-31	Cantor Fitzgerald	$985	14.2% downside
2025-10-09	Cantor Fitzgerald	$925	19.4% downside

Lilly(Eli) (LLY) FAQ

Lilly(Eli)'s target price stands at $1.3K. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $1.3K for LLY implies 16.7% upside versus today's price ($1148.2). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Lilly(Eli)'s target price evolved across reporting periods, while the comparison chart places LLY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Lilly(Eli)'s reading of $1.3K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.